Céline M Laumont

7PUBLICATIONS
103CO-AUTHORS
Cancer geneticsPredictive and prognostic markersTumour immunologyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 13, 2026
Rethinking ovarian cancer III: the past decade and future directions.

Frances R Balkwill, Céline M Laumont, Nikki Burdett

|Apr 01, 2026
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma.

Tibor A Zwimpfer, Sian Fereday, Ahwan Pandey

|Nov 21, 2025
Phenotypic Characterization and Prognostic Impact of CD103+ Tissue-Resident Memory T Cells in Diffuse Large B-cell Lymphoma.

Gillian Savage, Katy Milne, Brett Collinge

|May 15, 2024
N-MYC impairs innate immune signaling in high-grade serous ovarian carcinoma.

Alex Miranda, Swetansu Pattnaik, Phineas T Hamilton

|Oct 23, 2023
BioCanRx Summit for Cancer Immunotherapy 2022 Proceedings.

Stacey N Lee, Victoria Hoskin, Céline M Laumont

|Apr 08, 2022
Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities.

Céline M Laumont, Allyson C Banville, Mara Gilardi

Pageof 2